Home » Stocks » IRMD

IRadimed Corporation (IRMD)

Stock Price: $28.79 USD -0.16 (-0.55%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
Market Cap 354.48M
Revenue (ttm) 32.26M
Net Income (ttm) 986,639
Shares Out 12.31M
EPS (ttm) 0.08
PE Ratio 355.43
Forward PE 48.31
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $28.79
Previous Close $28.95
Change ($) -0.16
Change (%) -0.55%
Day's Open 28.97
Day's Range 28.31 - 28.80
Day's Volume 4,058
52-Week Range 20.46 - 29.98

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

iRadimed (IRMD) delivered earnings and revenue surprises of 44.44% and 10.34%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

WINTER SPRINGS, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices...

1 month ago - GlobeNewsWire

iRadimed (NASDAQ:IRMD) announces its next round of earnings this Friday, April 30. Here is Benzinga's look at iRadimed's Q1 earnings report.

1 month ago - Benzinga

WINTER SPRINGS, Fla., April 09, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market open...

2 months ago - GlobeNewsWire

WINTER SPRINGS, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market open...

4 months ago - GlobeNewsWire

The S&P 500 Index stocks saw their aggregate trailing 12-month real revenue per share rise at a compound average growth rate (CAGR) of 1.97% per annum over the past five years, which occurred alongside ...

Other stocks mentioned: EXPI, FLNT
5 months ago - GuruFocus

IRadimed Corporation (IRMD) CEO Roger Susi on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

IRadimed Corporation's (IRMD) CEO Roger Susi On Q3 2020 Results - Quick Version Earnings Call Transcript

7 months ago - Seeking Alpha

iRadimed (IRMD) delivered earnings and revenue surprises of 120.00% and 3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

WINTER SPRINGS, Fla., Oct. 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...

7 months ago - GlobeNewsWire

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

WINTER SPRINGS, Fla., Oct. 08, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market opens...

8 months ago - GlobeNewsWire

IRadimed Corp (IRMD) CEO Roger Susi on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

iRadimed (IRMD) delivered earnings and revenue surprises of 225.00% and 22.96%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

WINTER SPRINGS, Fla., July 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical device...

10 months ago - GlobeNewsWire

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10 months ago - Zacks Investment Research

WINTER SPRINGS, Fla., July 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market op...

10 months ago - GlobeNewsWire

WINTER SPRINGS, Fla., May 29, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s P...

1 year ago - GlobeNewsWire

Latest patent expands previous claims around IRADIMED’s wireless communication as used to remotely control an IV pump Latest patent expands previous claims around IRADIMED’s wireless communication as us...

1 year ago - GlobeNewsWire

IRadimed's (IRMD) CEO Leslie McDonnell on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

iRadimed (IRMD) delivered earnings and revenue surprises of 50.00% and -0.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Shares of iRadimed (NASDAQ:IRMD) rose 0.2% after the company reported Q1 results.

1 year ago - Benzinga

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Expects first quarter 2020 revenue of $8.6 million to $8.7 million Expects first quarter 2020 revenue of $8.6 million to $8.7 million

1 year ago - GlobeNewsWire

IRadimed's (IRMD) CEO Leslie McDonnell on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

iRadimed (IRMD) delivered earnings and revenue surprises of 50.00% and -0.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

WINTER SPRINGS, Fla., Jan. 07, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effect...

1 year ago - GlobeNewsWire

These companies are somewhere past proof of concept and on the road to profitability or already profitable.

Other stocks mentioned: FLYLF, GNSS, OSSIF, SYATF, ZYXI
1 year ago - Seeking Alpha

WINTER SPRINGS, Fla., Dec. 12, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only k...

1 year ago - GlobeNewsWire

IRADIMED Corporation (IRMD) CEO Leslie McDonnell on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

iRadimed (IRMD) delivered earnings and revenue surprises of 53.33% and 1.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

WINTER SPRINGS, Fla., Oct. 30, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only k...

1 year ago - GlobeNewsWire

IRMD will soon report record revenue and improving margins for a fourth consecutive quarter.

1 year ago - Seeking Alpha

WINTER SPRINGS, Fla., Oct. 08, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving al...

1 year ago - GlobeNewsWire

IRadimed is a leader in developing innovative MRI (Magnetic Resonance Imaging) compatible medical devices and accessories.

1 year ago - Seeking Alpha

WINTER SPRINGS, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chie...

1 year ago - GlobeNewsWire

IRadimed Corp (IRMD) CEO Roger Susi on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

IRMD is the only known provider of non-magnetic MRI compatible products in the U.S.

1 year ago - Seeking Alpha

IRadimed Corp (IRMD) CEO Roger Susi on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensor... [Read more...]

Industry
Medical Devices
IPO Date
Jul 16, 2014
CEO
Leslie McDonnell
Employees
110
Stock Exchange
NASDAQ
Ticker Symbol
IRMD
Full Company Profile

Financial Performance

In 2020, IRadimed's revenue was $31.72 million, a decrease of -17.65% compared to the previous year's $38.52 million. Earnings were $1.37 million, a decrease of -85.79%.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for IRadimed stock is "Buy" and the 12-month stock price forecast is 33.00.

Price Target
$33.00
Analyst Consensus: Buy